News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Argos Therapeutics, Inc. Expands Global Patent Protection


9/6/2012 9:31:00 AM

DURHAM, N.C., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced it was recently granted two patents and one patent allowance from the United States Patent and Trademark Office (USPTO) and one patent allowance from the European Patent Office (EPO). These new patents and allowed patent applications cover compositions of matter and methods of use related to Argos' proprietary immunotherapy technologies.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES